H.C. Wainwright Downgrades Lyra Therapeutics (LYRA) to Neutral
Tweet Send to a Friend
(Updated - May 7, 2024 6:11 AM EDT)
H.C. Wainwright analyst Matthew Caufield downgraded Lyra Therapeutics (NASDAQ: LYRA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Matthew Caufield downgraded Lyra Therapeutics (NASDAQ: LYRA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
